Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome

Eur Neurol. 2001;45(4):287-8. doi: 10.1159/000052146.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Botulinum Toxins, Type A / administration & dosage
  • Botulinum Toxins, Type A / therapeutic use*
  • Dystonic Disorders / complications*
  • Dystonic Disorders / drug therapy*
  • Humans
  • Injections, Intramuscular
  • Jaw Diseases / complications*
  • Jaw Diseases / drug therapy*
  • Male
  • Neuromuscular Agents / administration & dosage
  • Neuromuscular Agents / therapeutic use*
  • Pantothenate Kinase-Associated Neurodegeneration / complications*

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A